Drug Shortage Report for MINT-OSELTAMIVIR
| Report ID | 152092 |
| Drug Identification Number | 02497476 |
| Brand name | MINT-OSELTAMIVIR |
| Common or Proper name | Oseltamivir |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OSELTAMIVIR |
| Strength(s) | 75MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 10 count blisters |
| ATC code | J05AH |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-01-05 |
| Actual start date | |
| Estimated end date | 2023-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-01-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-01-03 | French | Compare |
| v4 | 2023-01-03 | English | Compare |
| v3 | 2022-01-06 | English | Compare |
| v2 | 2022-01-05 | French | Compare |
| v1 | 2022-01-05 | English | Compare |
Showing 1 to 5 of 5